Authors: MILES S LEVINE A FELDSTEIN M CARDEN J CABRIALLAS S MARCUS S MITSUYASU R GILL P

Citation: S. Miles et al., OPEN-LABEL PHASE-I STUDY OF COMBINATION THERAPY WITH ZIDOVUDINE AND INTERFERON-BETA IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA - AIDS CLINICAL-TRIALS GROUP PROTOCOL-057, Cytokines cellular & molecular therapy, 4(1), 1998, pp. 17-23

Authors: LEE FC LEIBLIN A CARDEN J MILES S MITSUYASU R

Citation: Fc. Lee et al., VIRAL LOAD CHANGES IN PATIENTS UNDERGOING CHEMOTHERAPY FOR AIDS-KS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 21-21

Authors: FAHEY JL MITSUYASU R

Citation: Jl. Fahey et R. Mitsuyasu, IMMUNOMODULATORY APPROACHES TO THE THERAPY OF AIDS, CLINICAL IMMUNOTHERAPEUTICS, 6(1), 1996, pp. 39-53

Authors: SYLVESTER A CALIENDO A AN D SAVARA A BYINGTON R STRICK D LILLANEY R SUTTON L SEPKOWITZ K FISCHL M SIMON G LALEZARI J MITSUYASU R DAQUILA R

Citation: A. Sylvester et al., HIV-1 RESISTANCE MUTATIONS AND PLASMA RNA DURING ZIDOVUDINE PLUS ZALCITABINE COMBINATION THERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 47-47

Authors: ALLAN JD MITSUYASU R LAVELLE JP CONANT MA TWADDELL T KAHN JO

Citation: Jd. Allan et al., SAFETY AND IMMUNOGENICITY OF MN AND IIIB RGP120 HIV-1 VACCINES IN HIV-1-INFECTED SUBJECTS WITH CD4 COUNTS GREATER-THAN-500 CELLS/MM(3)/, AIDS research and human retroviruses, 10, 1994, pp. 190000157-190000157

Authors: YU K MITSUYASU R

Citation: K. Yu et R. Mitsuyasu, RELATIVE INCIDENCE OF INFECTION DURING NEUTROPENIA - A RETROSPECTIVE COMPARISON BETWEEN HIV-LESS-THAN-500 AND ANC=500-750( PATIENTS WITH ANC), Clinical research, 42(2), 1994, pp. 10000278-10000278